↓ Skip to main content

Immunogenicity, Reactogenicity, and Safety of a P1.7b,4 Strain-Specific Serogroup B Meningococcal Vaccine Given to Preteens▿

Overview of attention for article published in Clinical and Vaccine Immunology (formerly CDLI), September 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy
2 policy sources
patent
1 patent

Readers on

mendeley
24 Mendeley